Ascendis Pharma AS (NAS:ASND)
$ 124.33 -2.22 (-1.75%) Market Cap: 7.43 Bil Enterprise Value: 7.88 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

Ascendis Pharma A/S Presents At Bank of America Securities 2021 Healthcare Conference (Virtual) Transcript

May 11, 2021 / 08:15PM GMT
Release Date Price: $133.64 (+2.74%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Good afternoon, everyone. Thanks for joining us back here at the Bank of America Healthcare Conference. It's my pleasure to have our next presenting company. Several members from the management team of the Ascendis are going to be chatting with me for the next 30 minutes. Unfortunately, they can see me, but I can't see them. So Jan and team, I'm going to turn it over to you guys to introduce yourselves. And then hopefully, we can just get into some Q&A, if that makes sense.

Jan Moller Mikkelsen;S;President
Ascendis Pharma A;CEO, Member of Executive Board & Executive Director

/- -

Thanks a lot, Tazeen. And I can start, Jan Mikkelsen, and then we have.

Scott T. Smith;S;CFO;Dana Pizzuti;S;SVP of Development Operations
Ascendis Pharma A;Senior VP & Member of Executive Board;Ascendis Pharma A

/- -

Scott Smith, CFO.

- /

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot